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Background: Non-random segregation of DNA strands during stem cell replication has been proposed as a mechanism to
minimize accumulated genetic errors in stem cells of rapidly dividing tissues. According to this hypothesis, an “immortal”
DNA strand is passed to the stem cell daughter and not the more differentiated cell, keeping the stem cell lineage replication
error-free. After it was introduced, experimental evidence both in favor and against the hypothesis has been presented.
Principal findings: Using a novelmethodology that utilizes cancer sequencing datawe are able to estimate the rate of accumulation
of mutations in healthy stem cells of the colon, blood and head and neck tissues. We find that in these tissues mutations in stem cells
accumulate at rates strikingly similar to those expected without the protection from the immortal strand mechanism.
Significance: Utilizing an approach that is fundamentally different from previous efforts to confirm or refute the immortal
strand hypothesis, we provide evidence against non-random segregation of DNA during stem cell replication. Our results
strongly suggest that parental DNA is passed randomly to stem cell daughters and provides new insight into the mechanism of
DNA replication in stem cells.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Before a cell divides, its DNA content is replicated and then
segregated during mitosis. Whether the DNA strands are
passed randomly to the two daughter cells or according to
some other mechanism is however not clear.⁎ Corresponding author at: Division of Biostatistics and Bioinformatics,
Department of Oncology, Sidney Kimmel Comprehensive Cancer
Center, Johns Hopkins University School of Medicine, 550 North
Broadway, Suite 1103, Baltimore, MD 21205-2013, USA.
E-mail address: ctomasetti@jhu.edu (C. Tomasetti).
http://dx.doi.org/10.1016/j.scr.2015.01.005
1873-5061/© 2015 The Authors. Published by Elsevier B.V.
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ThisThe immortal DNA strand hypothesis has been proposed
(Cairns, 1975) as a mechanism used by stem cells in order to
minimize the accumulation of mutations in their genomes.
This hypothesis proposes that stem cells divide predomi-
nantly asymmetrically, producing one stem cell and one
differentiated cell, and that at each division, a template
set of DNA strands (known as the “parental” or “immortal
strands”) is transferred to the daughter stem cell and not to
the non-stem cell daughter. The fundamental idea behind
this hypothesis is that, by retaining the immortal strands
within the stem cell progeny, the accumulation of random
DNA replication errors in the stem cell compartment wouldis an open access article under the CC BY-NC-ND license
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239The (not so) immortal strand hypothesisbe greatly reduced, therefore decreasing the risk of genetic
disorders such as cancer. Indeed, errors in DNA duplication
would be passed on to non-stem, more differentiated, and
shorter-lived daughter cells.
The earliest experimental evidence for the non-random
segregation of stem cell DNA strands in mammalian tissues
comes from studies by Potten et al. of tongue epithelia
and intestinal crypts (Potten et al., 1978). Although some
further experimental work appears to support this hypoth-
esis (Potten et al., 2002; Smith, 2005; Karpowicz et al.,
2005; Shinin et al., 2006; Conboy et al., 2007; Armakolas
and Klar, 2007), whether such a mechanism is operational
in adult stem cells in vivo or not is still controversial
(Haber, 2006), with reports arguing against the existence
of immortal strands in intestinal crypts (Steinhauser et al.,
2012) and hematopoietic stem cells (Kiel et al., 2007).
Most of the studies arguing for or against the immortal
strand relied on labeling early stem cells and testing
whether segregation of label followed a random or
non-random pattern. Here we use a different approach
that utilizes genetic sequencing data and provide new
evidence against the immortal strand hypothesis, by
showing that stem cells in hematopoietic, colorectal and
head and neck epithelial tissues contain as many somatic
mutations as would be expected if no protection mecha-
nism were in place.function of age. A) Tomasetti et al. (2013) found that the
number of mutations in cancer tissues correlates significantly
with the age of the patient in chronic lymphocytic leukemia,
uterine corpus endometrioid carcinoma and colorectal cancer,
independent of the cancer stage. For example, colorectal cancers
in 85-year olds harbor on average 121 mutations, in contrast to
74 mutations in colorectal cancers of 45-year old patients.
B) Difference in the numbers of somatic mutations detected in the
cancers of patients of different ages can be explained by the
difference in the length of the self-renewal phase in the lineage
that lead to cancer. Thus the average difference in the numbers of
mutations in colorectal cancer patients aged 85 and 45 provides a
good estimate for the number of somatic mutations that accumu-
lated during 40 years of healthy self-renewal. This allows us to infer
the normal rate at which mutations accumulate in healthy stem
cells.Results
Tomasetti et al. (2013). recently provided a new methodol-
ogy for estimating the number of mutations that accumulate
in healthy self-renewing tissues. Their results were obtained
via the analysis of The Cancer Genome Atlas (TCGA) and the
International Cancer Genome Consortium (ICGC) whole-exome
sequencing data on somatic mutations from patients with a
given tumor type. Tomasetti et al. found statistically significant
strong positive correlations between age and number of somatic
mutations in tumors of several self-renewing tissues, in patients
with matched tumor stages (Fig. 1A). For example, the data
show that colorectal cancers from 85-year-old patients have, on
average, 47 mutations more than colorectal cancers at the
same stage from 45-year-old patients. Since the cancer stage is
the same, those extra 47 mutations are, on average, not due to
the cancer phase, but to the normal accumulation of somatic
mutations occurring in the healthy tissue during the extra time
the older patients had before tumorigenesis started (Fig. 1B).
This allows the estimation of the rate at which mutations
accumulate in healthy cells, prior to the first driver mutation
hit. This method represents a unique way of indirect single cell
sequencing, since all tumor cells carry the changes present in
their last healthy ancestor in addition to changes accumulated
during tumor evolution (Fig. 1B). Importantly, their results
yielded estimates for the rate of accumulation of somatic
mutations in healthy tissues that are remarkably in line with
estimates obtained via completely different methodologies
(Tomasetti et al., 2013).
The first initiating event that starts the process of
tumorigenesis must originate in a healthy cell. It is possible
that this healthy cell may not be a stem cell (O'Brien et al.,
2007). However, given any cell of a healthy self-renewing
tissue, the number of divisions that separates this cell fromits mother stem cell is not very large. And even a hundred
divisions will not create any relevant difference between the
mutational load of the stem cell mother and its healthy
differentiated daughter cell. In fact, normal somatic muta-
tion rates are of the order of 10−10 per base per cell division
(Tomasetti et al., 2013), and therefore 100 divisions will not
cause, on average, even one extra point mutation in the
exome of the differentiated cell. Thus, we can safely assume
that the mutational load found in healthy cells is an accurate
estimate for the mutational load of their mother stem cells.
We are then able to provide estimates for the number of
somatic mutations accumulating in healthy stem cells of
self-renewing tissues as a function of time. In Fig. 2A, we
show the average number of somatic mutations accumulat-
ing with age in stem cells of the colonic crypt (red line), plus
or minus 2 standard errors (shaded red area), as it was
estimated from TCGA sequencing data in Tomasetti et al.
(2013). We next compare these estimates with the number
240 C. Tomasetti, I. Bozicof somatic mutations expected to be present in healthy stem
cells of the colonic crypt if we assume that the epithelial
lining of the colon regenerates approximately every week
(van der Flier and Clevers, 2009), and that, contrary to the
immortal strand hypothesis, the parental DNA strands were
randomly assigned to either of the daughter cells (blue and
green lines).
The estimates for the mutational load from sequencing
data are strikingly similar to the expected mutational load in
healthy cells without the protection of an immortal strand
(Tomasetti et al., 2013; Araten et al., 2005; DeMars and
Held, 1972; Drake et al., 1998) (Fig. 2A). Thus we see no
evidence for the protection afforded by immortal strands on
the rate of mutation accumulation in healthy colon tissue.
Further comparisons are provided in Fig. 2B,C for blood,
where there is evidence of stem cell asymmetric divisions
(Ting et al., 2012), as well as head and neck epithelial stem
cells of never-smokers, since tongue epithelia was one of the
two first tissues on which evidence in favor of the immortal
strand hypothesis was provided (Potten et al., 1978).
Similarly as in the case for colon, the predicted mutational
load assuming no protection from the immortal strand is very
similar to the mutational load inferred from sequencing data
for these two tissues.Conclusions
Our results provide new evidence against the immortal DNA
strand hypothesis, specifically for colon, blood and head andFigure 2 Estimates for mutational load obtained from sequencin
healthy cells without the protection of an immortal strand. Re
accumulating with age in stem cells of the colonic crypt, plus or min
TCGA sequencing data in Tomasetti et al. 2013. Expected mutatio
immortal strand is represented by the gray cone in-between the
evidence of the stem cells enjoying a protection mechanism reduci
confidence interval (red cone) would have to be significantly below
where the confidence interval is very large, the lower bound of thisneck epithelial stem cells. We find evidence that the healthy
stem cell divisions did not include asymmetric segregation of
an “immortal strand”, since the stem cells responsible for
maintaining the tissue accumulated replication errors at
normal rates. We cannot rule out the existence of a separate
pool of tissue-maintaining stem cells that are retaining
immortal strands and whose progeny never (or very rarely)
give rise to tumors, as our methodology would not be able to
sample them, but there is no evidence that such a stem cell
pool exists. Similarly, our analysis cannot not rule out the
existence of a pool of quiescent stem cells that rarely divide
on which this mechanism might operate, but there is no
evidence from our data that such cells are involved in tissue
maintenance in colon, blood and epithelial cells of the head
and neck.Materials and methods
The mutational load as a function of age was obtained from
the publicly available The Cancer Genome Atlas (TCGA)
database for the indicated tissues. More specifically, the red
lines in Fig. 2 represent the average number of somatic
mutations accumulating with age in stem cells of the colonic
crypt, plus or minus 2 standard errors (shaded red area), as
estimated from TCGA sequencing data using the robust
regression described in Tomasetti et al. (2013).
The expected mutational load in healthy stem cells
without the protection from the immortal strand is instead
represented by the blue and green lines in Fig. 2. In order tog data are strikingly similar to the expected mutational load in
d line represents the average number of somatic mutations
us 2 standard errors (shaded red area), as it was estimated from
nal load in healthy stem cells without the protection from the
blue and green lines (see Materials and methods section). For
ng the accumulation of random mutations, the red line with its
the gray cone, which is never the case. And in head and neck,
interval is just below the blue line, as in blood.
241The (not so) immortal strand hypothesisobtain these estimates, the formulas for the expected
values, as found in Tomasetti et al. (2013) were used. In
particular, the somatic mutation rate per cell division per
nucleotide base has been estimated via various orthogonal
methods (Tomasetti et al., 2013; Araten et al., 2005; DeMars
and Held, 1972; Drake et al., 1998) to be 1.4 · 10−10 in
human fibroblasts, and 0.66 · 10−10 in B-lymphoblastoid. We
have used a mutation rate equal to 5 · 10−10 (blue line)
(Tomasetti et al., 2013) and, to be conservative, an even
higher 10−9 (green line) per cell division per nucleotide base.
Stem cell division rates were assumed to be once a month in
blood (Kiel et al., 2007) and once a week in colon (van der
Flier and Clevers, 2009) and head and neck epithelium
(Gillespie, 1969).
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